📢 Here's the upcoming #EuroELSOwebinar: Evolving concepts in anticoagulation and antiplatelets in VA #ECMO #ECPR & VV #ECLS
🗓️ March 25 2026, 16:00-17:00 CET
Register now! 🖋 www.euroelso.net/webinars/
🎥 PS all EuroELSO webinars are available on demand, open access! #FOAMcc
🔓 bit.ly/EuroELSOyout...
📖 VV #ECMO in adults! Chapter 15 is focused on adult in respiratory failure
🩸 cannulation
📋 nomenclature for #ECLS configurations
💨 hypoxemia/hypercapnia on VV ECMO
🫁 ventilation/proning
🫁 weaning
📘 Blue Book: latest edition of ELSO
#ECMO Specialist Training Manual is available
🛒 bit.ly/ELSObooks
#ECMO without anticoagulation: are we there yet?
🩸 Novel coatings, strategies as NO in SGF, new anticoagulants hold promise of reduce risks. Awaiting further evidence, anticoagulation-free #ECLS should be an exception, maybe safe in some highly selected adults on VV with relatively high blood flows.
#ECMO without systemic anticoagulation? Editorial
🔗 bit.ly/4u6yqUd
🩸 Refers to study investigating association between systemic anticoagulation & outcomes in patients with #ARDS receiving VV #ECLS. Authors observed no link between systemic anticoagulation and
short-term survival.
🔗 bit.ly/3P1pkrv
📦📦 #ECMO Equipment survey!!
ELSO is surveying ECMO centers to understand #ECLS equipment availability challenges and how these affect care/case volume. Your confidential input will help guide engagement with regulators and industry.
📆 Respond by March 31, 2026.
🖋️ bit.ly/ECMOEquip2026
Antimicrobial stewardship in #ECMO? Challenging & evolving discipline, w limited data available!
🧫 PK alterations induced by circuits + prolonged ICU stays + high infection risk make optimal ABT therapy complex. Evidence for use of stewardship in #ICU remains applicable to #ECLS.
🔗 bit.ly/4cXVzlj
Antimicrobial stewardship in #ECMO
🧫 infections & 🧪 infection biomarkers during #ECLS
💉 PK/PD & appropriate antimicrobial dosing
💉 antibiotic prophylaxis in ECMO: yes or no?
🔮 empirical ABTS and circuit/cannula change
🩺 ABT stewardship and diagnostic
🚧 infection control strategies
🔗 bit.ly/4cXVzlj
Prolonged VA #ECMO? Characterizing patients requiring long run in the PRECISE-ECLS cohort
🔍 29% prolonged #ECLS
🔎 1y mortality/HRQoL comparable for pts who received support for 7 days/longer
A prediction model may assist in decision-making regarding treatment goals beyond first week
🔓 rdcu.be/e6gIm
📢 Our newsletter is out!
🖋️ Message from our President
📆 Mark calendars: #ECMO Team Day is May 8th!
🛏 Circuit Chatter: special edition
📃 News from ELSO Committees
📆 Save the date for #ELSO2026
🌏 #ECLS around the world, updates from ELSO Chapters
🖋️ CEO remarks & more!
🔗 bit.ly/2IR8RCl
📖 VV #ECMO in children Chapter 14 is focused on neonates and pediatric patients experiencing respiratory failure:
🫁 history of veno-venous #ECLS
🫁 neonatal respiratory ECMO
🫁 pediatric VV ECMO
🫁 patients & circuit management
📘 The Blue Book is available in our bookstore!
🛒 bit.ly/ELSObooks
🚡 #KeystoneECMO, the #ECMO & the advanced therapies for cardiovascular and respiratory failure conference, is ongoing in Colorado! 🌨️
The 42nd Annual Children's National Symposium is addressing the educational needs of health care workers involved in the care of patients in #ECLS.
Understanding when not to start #ECLS is equally as important as knowing when to withdraw – new #editorial from Rajsic et al.
www.bjanaesthesia.org/article/S0007-0912(25)00...
🫁 M Baram will present on VV #ECLS: principles of pt selection, physiology, management strategies to optimize respiratory support
🫀P Mason will present on VA #ECMO: hemodynamic support, decision-making, complexities of managing pts requiring cardiac/cardiopulmonary support
🔗 bit.ly/49nEhL5
#SCCM2026
⚙️ #ECMO continues to evolve: education remains foundation of safe, effective care!
Join ELSO & @sccmcriticalcare.bsky.social pre #SCCM2026 course for two exceptional 1️⃣ day programs to strengthen clinical understanding and decision-making across #ECLS
📌 Chicago, IL
📅 March 20 & 21
🔗 bit.ly/49nEhL5
Temporary mechanical support in fulminant myocarditis
🔍 patients treated with VA #ECMO and/or #Impella from FULLMOON study
🫀 FM requiring t-MCS associated with high 1-year mortality = 36%, even if young cohort: rapid recognition + timely transfer to specialized #ECLS centers pivotal
🔓 rdcu.be/e4IBX
#ECMO center volume: any association with #ECLS related complications? Analysis of @theelso.bsky.social Registry.
Higher volume may lead to ⬆️ experience translating to ⬆️ vigilance = early detection of ECMO complications, but also to initiation within larger, more complex population.
🖇️ bit.ly/3MP3mr1
📘 Blue Book: #ECMO Specialist Training Manual chapter 13, #ECLS circuit & component changes
⚙️ pt management
⚙️ change-out supplies/procedure
⚙️ circuit & selective components replacement: ML, pump-head/raceway, tubing, connector, stopcock/pigtail, AV bridge
⚙️ post-replacement phase
🛒 bit.ly/ELSObooks
Exploratory laparotomy in patients on #ECMO
🔍 >1,3K #ECLS patients: 4% abdominal exploration
🔪 procedures pts resection of necrotic bowel, repair of perforations, other
🪦 mortality 57%; higher disease severity scores/mesenteric ischemia: significant factors influencing mortality
🔗 bit.ly/4alLSvB
Prone positioning in VV #ECMO?? no net physiological benefit after #ECLS initiation in this animal model 🐖 with severe #ARDS randomized after VV initiation to prone or supine positioning for 48 h, receiving an ultraprotective MV strategy 🫁
Open access #FOAMcc #FOAMecmo
🔓 rdcu.be/e28tP
📖 Monitoring #extracorporeal circuit and pt on #ECLS: Blue Book, chapter 12
🖥️ circuit: pressures, EBF meters, air/bubble detectors, OxyHb monitoring, temperature
🖥️ patient: arterial BP, SpO2, Sc/SVO2, rSO2, EtCO2, PAC, #POCUS, neuromonitoring
📘 the #ECMO Specialist Training Manual
🛒 bit.ly/ELSObooks
📖 Priming the #ECLS: let's open the Blue Book! Chapter 11 is focused on this practice, essential to initiate #ECMO support:
📦 pre-priming
💧crystalloid prime
🩸blood prime
The chapter includes online supplementary files available for download
📘 the #ECMO Specialist is available!
🛒 bit.ly/ELSObooks
Ultrasound in #ECMO? #POCUS ubiquitous & indispensable in the care of #ECLS patients, from indication to choice of configuration, cannulation, monitoring, weaning and post decannulation.
@asaiojournal.bsky.social #FOAMcc #FOAMecmo #FOAMus #echofirst
🔓 bit.ly/4bUMDN6
Ultrasound in #ECMO state-of-the-art review
📚 training for #ultrasound in #ECLS
🖥️ choice of mode
🫀🫁 US pre Initiation in CS & respiratory failure
🍼 neonatal & pediatric considerations #PedsICU
🖥️ role for cannulation
🖥️ monitoring & troubleshooting
🖥️ vascular US
🧠 neuro US
🖥️ weaning
🔓 bit.ly/4bUMDN6
Getinge Reports Strong Q4 and Full-Year Growth Amid Challenges for 2025 #Sweden #Gothenburg #Getinge #ECLS #Cardiosave
Conversion from VV to VA or hybrid #ECMO, analysis of ELSO Registry including 29K adults
🫀 2.4% received a change from original configuration, 56.8% to VA, 43.2% to hybrid #ECLS
⚖️ increased clinical & circuit complications reported in converted patients; in-hospital mortality higher
🔗 bit.ly/4pT9Na1
Preoperative #ECMO in children with dextro-TGA undergoing arterial switch operation
🔍 analysis of ELSO Registry, 2000-22
🍼 100 neonates aged up to 21 days
🪦 overall mortality 33%
⚖️ 70% underwent ASO on #ECLS; they had more complications/higher mortality (61%) vs those weaned preop
🔗 bit.ly/4bCrU0n
VenoPulmonary #ECLS: current use across different clinical conditions, adverse events, outcomes, prognostic drivers:
🫀🫁 VP #ECMO chiefly used for HF/CS (54.4%) and ARF/ARDS (26.6%): hospital outcomes, complications and survival differed according to diagnosis leading to VP ECLS 🔗 bit.ly/4pKMHSS
VP #ECLS: @theelso.bsky.social Registry analysis including 838 patients receiving VP as first support modality, July 2020 - July 2024
🫀🫁 chiefly used for HF/CS or ARF/ARDS
🪦 60-day mortality 49.3%; advanced age, female sex, BMI, CRRT use prior to cannulation predictors of death
🔗 bit.ly/4pKMHSS
Death by neurologic criteria in neonates undergoing #ECMO
🔍 @theelso.bsky.social Registry Study, 2010–2023, including about 15K neonates (≤28 days old, born after 37 weeks gestation) on #ECLS
🪦 DNC rarely diagnosed: 0.5% neonates
⏱️ 84% DNC diagnoses occurred after 24 hours of run
🔓 bit.ly/49zx4sV
Death by neurologic criteria in neonates undergoing #ECMO
🪦 DNC rare: 0.5%, 2% of overall mortality
⚖️ factors associated w greater risk pre-ECMO CA, severe acidosis, cardiac support/central cannulation, hyperoxemia
Optimizing #ECLS management pivotal!
@pedcritcaremed.bsky.social
🔓 bit.ly/49zx4sV
